J Korean Med Assoc.  2016 Nov;59(11):842-846. 10.5124/jkma.2016.59.11.842.

The diagnosis of osteoporosis

• Jeon YK
• Kim BH
• Kim IJ

• KMID: 2358431
• DOI: http://doi.org/10.5124/jkma.2016.59.11.842

Abstract

Osteoporosis has been defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and a consequent increase in fracture risk. The World Health Organization's standard criterion for the diagnosis of osteoporosis in postmenopausal women and older men is a T-score of ≤-2.5 at the lumbar spine, femur neck, or total hip by bone mineral density measured by dual energy X-ray absorptiometry. To diagnose osteoporosis, quantitative computed tomography, and ultrasound can be used. In this article, we will discuss the methods of diagnosing osteoporosis including imaging techniques and serum turnover markers and the indications of osteoporosis.

Keyword

Bone density; Osteoporosis; Computed tomography; Ultrasonography

MeSH Terms

Absorptiometry, Photon
Bone and Bones
Bone Density
Diagnosis*
Female
Femur Neck
Global Health
Hip
Humans
Multiple Endocrine Neoplasia Type 1
Osteoporosis*
Spine
Ultrasonography

Reference

1. Watts NB. Clinical utility of biochemical markers of bone remodeling. Clin Chem. 1999; 45:1359–1368.

2. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000: highlights of the conference. South Med J. 2001; 94:569–573.

3. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group. World Health Organ Tech Rep Ser. 1994; 843:1–129.

4. Cheng S, Suominen H, Sakari-Rantala R, Laukkanen P, Avikainen V, Heikkinen E. Calcaneal bone mineral density predicts fracture occurrence: a five-year follow-up study in elderly people. J Bone Miner Res. 1997; 12:1075–1082.

5. Schousboe JT, Shepherd JA, Bilezikian JP, Baim S. Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on bone densitometry. J Clin Densitom. 2013; 16:455–466.

6. Baim S, Wilson CR, Lewiecki EM, Luckey MM, Downs RW Jr, Lentle BC. Precision assessment and radiation safety for dual-energy X-ray absorptiometry: position paper of the International Society for Clinical Densitometry. J Clin Densitom. 2005; 8:371–378.

7. Engelke K, Adams JE, Armbrecht G, Augat P, Bogado CE, Bouxsein ML, Felsenberg D, Ito M, Prevrhal S, Hans DB, Lewiecki EM. Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults: the 2007 ISCD Official Positions. J Clin Densitom. 2008; 11:123–162.

8. Engelke K, Lang T, Khosla S, Qin L, Zysset P, Leslie WD, Shepherd Schousboe JT. Clinical use of quantitative computed tomography (QCT) of the hip in the management of osteoporosis in adults: the 2015 ISCD official positions–part I. J Clin Densitom. 2015; 18:338–358.

9. Krieg MA, Barkmann R, Gonnelli S, Stewart A, Bauer DC, Del Rio Barquero L, Kaufman JJ, Lorenc R, Miller PD, Olszynski WP, Poiana C, Schott AM, Lewiecki EM, Hans D. Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official Positions. J Clin Densitom. 2008; 11:163–187.

10. Szulc P, Delmas PD. Biochemical markers of bone turnover: potential use in the investigation and management of post-menopausal osteoporosis. Osteoporos Int. 2008; 19:1683–1704.

11. Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R. National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014; 25:2359–2381.

12. Girgis CM, Seibel MJ. Atypical femur fractures: a review of the evidence and its implication to clinical practice. Ther Adv Musculoskelet Dis. 2011; 3:301–314.

13. Allen MR. Animal models of osteonecrosis of the jaw. J Musculoskelet Neuronal Interact. 2007; 7:358–360.

14. Allen MR. Bisphosphonates and osteonecrosis of the jaw: moving from the bedside to the bench. Cells Tissues Organs. 2009; 189:289–294.